Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/20/2009

------ ------- ------ ------- Total costs and expenses 233,637 277,104 740,382 834,599 Operating loss (22,402) (58,742) (126,101) (196,981) Interest and other income, net (4,257) (5,338) (8,507) (4,789) Loss on impairment of investments - (14,943) (1,377) (14,943) ------ ------ ----- ------ Net loss $(26,659) $(79,023) $(135,985) $(216,713) ======== ======== ========= ========= Net loss per share - basic and diluted $(0.19) $(0.58) $(0.97) $(1.58) ====== ====== ====== ====== Shares used in computing net loss per share - basic and diluted 141,308 137,389 140,350 136,799

A reconciliation of reported GAAP operating loss to non-GAAP operating income (loss) excluding non-cash items and one-time items is provided in the table that follows (in thousands, unaudited):


                                       Quarter ended      Nine months ended
                                        September 30,        September 30,
                                       2009      2008      2009        2008
                                       ----      ----      ----        ----
    GAAP operating loss             $(22,402) $(58,742) $(126,101) $(196,981)

    Stock-based compensation          10,900    14,009     33,947     43,011
    Other non-cash compensation        4,392     5,531     15,719     18,847
    Depreciation and amortization      8,733     7,594     26,587     21,333
    Amortization of deferred revenue  (1,033)   (1,071)    (3,176)    (3,214)
    Restructuring                          -         -     11,376          -
                                       -----    ------     ------     ------

    Non-GAAP operating 
'/>"/>
SOURCE  Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... and advisory firms for pharmaceutical and healthcare issues, ... that therapies offering a greater effect on quality ... unmet need. Given the high level of subjectivity ... of life, interviewed thought leaders state that it ...
(Date:5/19/2013)... Calif. , May 20, 2013  Whole-cell pertussis ... acellular pertussis vaccines during a large recent outbreak, according ... Whole-cell pertussis vaccines, also called DTwP, were ... with safety concerns that ultimately led to the development ... By the late 1990s, the United States ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... ST. LOUIS, Oct. 20 Stereotaxis, Inc. (Nasdaq: ... launched the Odyssey Interventional Network, a training and ... cardiovascular community.  The portal will showcase innovative electrophysiology ... centers around the world.  The Odyssey Interventional Network ...
... 20 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ... nine analyses relating to its LEVADEX™ orally inhaled ... FREEDOM-301 Phase 3 trial, at the 2010 European ... Nice, France.  EHMTIC is a biennial congress of ...
Cached Medicine Technology:Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 2Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 3Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 4MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 2MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 3MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 4
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... are twice as likely to become obese adults as ... young, a new 30-year study shows. Researchers found ... higher body-mass index (BMI) and obesity, even if they ... no difference; well-off or poor, they tended toward ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... Join Seva Foundation in celebrating its 35th Anniversary with ... Fine Arts Theater in San Francisco, featuring: Snatam ... with host Wavy Gravy. All proceeds will benefit Seva Foundation’s ... seats are $40 & $55, VIP tickets are $150 and ... row seat at the show. Tickets are available through ...
(Date:5/20/2013)... A new Benefits of Pharmacy Home Delivery ... of the MedEx Pack announced. The new ... Delivery, in order to provide useful details for those who ... Clyde Furuta, MedEx Direct owner and pharmacist said, “One of ... a product like the MedEx Pack, patients can receive their ...
Breaking Medicine News(10 mins):Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2
... study finds , , FRIDAY, March 14 (HealthDay News) -- Higher ... harm older men, U.S. research shows. , A ... followed 1,000 seniors in three Florida retirement communities for up ... levels of anxiety at the start of the study lived ...
... Gottsch to Visit Washington, D.C., and Meet with Elected ... Boise,Idaho, will travel to Washington, D.C., this April 1 ... restoration of the,Americans with Disabilities Act, support for epilepsy ... epilepsy., Gottsch, 9, is one of 50 young ...
... Peter Serwik to Visit Washington, D.C., and Meet with ... of,Middletown, Del. will travel to Washington, D.C., this April ... for restoration of the,Americans with Disabilities Act, support for ... for epilepsy., Serwik, 7, is one of 50 ...
... C.J. Soeby to Visit Washington, D.C., and Meet With ... of Buckeye,Ariz. will travel to Washington, D.C., this April ... for restoration of the,Americans with Disabilities Act, support for ... for epilepsy., Soeby, 10, is one of 50 ...
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... Washington, D.C., this April 1 to meet,with congressional leaders ... Disabilities Act, support for epilepsy public health,programs and more ... is one of 50 young people with epilepsy participating ...
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... to Washington, D.C., this April 1 to meet,with congressional ... with Disabilities Act, support for epilepsy public health,programs and ... 16, is one of 50 young people with epilepsy ...
Cached Medicine News:Health News:Anxiety Helps Elderly Women Live Longer 2Health News:Idaho Youth Named National Epilepsy Spokesperson 2Health News:Delaware Youth Named National Epilepsy Spokesperson 2Health News:Arizona Youth Named National Epilepsy Spokesperson 2Health News:Vermont Youth Named National Epilepsy Spokesperson 2Health News:Virginia Youth Named National Epilepsy Spokesperson 2
... produce Type III, laboratory-grade pure water at ... directly with potable tap water and combine ... design that is easy to operate, reliable, ... produced at a low operating cost., Applications, ...
... systems produce Type III, laboratory-grade pure water ... fed directly with potable tap water and ... system design that is easy to operate, ... water produced at a low operating cost., ...
... chest freezer, with over 23 cu. ft. ... boxes. Built to the same standards as ... a cost-saving alternative. Rust-resistant, powder coated exterior; ... four adjustable shelves. Keyed lock and 4-digit ...
... Advanced Series CO2 Incubators by ... Microprocessor achieves precise temperature and ... evaporation & RH% is displayed ... and RH are displayed digiton ...
Medicine Products: